| Dr. Lyn Patrick N.D. | Full Bio |
|
| Why Some Chronic Cases Don’t Resolve: The Hidden Role of Toxicant Burden Evidence-Based Clinical Strategies for Assessment, Depuration, and Recovery |
| Toxicant exposure is a defining etiology for many of today’s chronic complex and acute illnesses. Especially in light of escalating cancer prevalence and increasing neurodegenerative disease, exposures from the womb to adulthood define our internal mileau. We know this not only from bloodwork at birth, but from adipose tissue biopsies and brain autopsies in the published literature.
Given that this is the hand we have been dealt is it possible to mitigate the damage from these toxicants that contribute to a vast array of health conditions? The answer is definitively YES. From the hundreds of studies looking at the mechanisms of damage to the less than 100 (but still sizeable) studies showing interventions can significantly reduce damage- we’ll review both avoidance, depuration, and intervention for toxicants like bisphenol A, pesticides, persistent organic pollutants (DDT, PCBs, etc.), solvents, and plastics, including microplastics! We’ll also review some case studies showing how this is done and why it works. |
|
| Dr. Bobby Parmar N.D. | Full Bio |
|
| BMI Misses Risk: Racial Adiposity Patterns, Metabolic Phenotypes, and Clinical Outcomes |
In this presentation, Dr. Parmar will explore how obesity prevalence, adiposity patterns, and downstream cardiometabolic risk differ across racial and ethnic groups, emphasizing person‑first care. The talk will review epidemiologic trends in overweight and obesity, highlight racial differences in visceral and subcutaneous fat distribution and “metabolically healthy” phenotypes, summarize disparities in diabetes, hypertension, NAFLD, cardiovascular disease, and obesity‑related mortality, examine structural racism, social determinants, and provider bias as key drivers of these patterns, and outline inequities in access to behavioral and pharmacologic treatments. |
|
| Dr. Leigh Arseneau N.D. | Full Bio |
|
| Precision Longevity: Evidence-Based Clinical Tools for Extending Healthspan: Personalized Strategies for Mitochondrial Resilience, NAD+ Support, and Healthy Aging Outcomes |
| Longevity medicine focuses on extending healthspan by addressing the emerging mechanisms of aging-related decline. For integrative healthcare practitioners, it builds on core principles of systems biology, personalized care, and early intervention. This lecture explores key aging pathways—such as genomic instability, immunosenescence and mitochondrial dysfunction.
Participants will learn practical, evidence-informed strategies and targeted supplementation, with a discussion of emerging therapies like NAD+ support and senolytics. Emphasis is placed on targeted and individualized care on how to integrate longevity medicine into clinical practice and improve long-term patient outcomes. |
|
Dr. Robert Rountree M.D. | Full Bio |
|
Metabolic Neuropsychiatry: Mitochondrial Strategies to Restore Mood, Cognition, and Brain Resilience |
| Mitochondria are essential organelles centrally involved in cellular energy production, signaling pathways, and synthesis of key hormones and biomolecules critical for maintaining health. Dysfunction in mitochondrial structure, quality control mechanisms, and function contributes significantly to the metabolic impairments observed in many chronic diseases. This is especially pronounced in the brain, one of the body's largest consumers of energy. Over the last decade, the emerging field of metabolic neuropsychiatry has focused on targeting these mitochondrial and metabolic abnormalities through dietary and lifestyle interventions.
This presentation will review evidence that mitochondrial and metabolic dysfunction underlie many mental and neurological disorders. It will further explore therapeutic and lifestyle strategies, including personalized dietary approaches such as nutritional ketosis and exercise regimens, aimed at restoring metabolic flexibility, enhancing mitochondrial function, and mitigating associated neuropathology. |
|
| Early Bird (ends May 24, 2026) Price USD $92 (~CAD $129) Regular Price (after May 24, 2026) Price USD $107 (~CAD $149) Receive USD $120 / CAD $159 Vita Aid Product Credit** |
| * The currency exchange rate varies; the price is based on CAD. ** Product credit is non-transferrable, not redeemable for cash, and can only be used once per account by a Licensed Health Care Practitioner / Medical Student towards the purchase of products through Vita Aid Professional Therapeutics directly. Free shipping criteria apply after applying the discount. Effective: June 13 - July 13, 2026. |
|
Pending Approval for CME (4.0) and Pharm. (0.25) for AANP /CONO |
|
Not Sure If You Can Attend Live? No Problem! The recording of each session will be provided to all registrants. |
|
Learn from expert speakers providing knowledge and clinical pearls that you can directly apply to transform your practice. |
|
Live Q&A Session and Raffle Prize Giveaways |
|
Conference Special Offers/Discounts from Our Sponsors |
|
| Vita Aid Professional Education #303-29285 Stewart Crescent, Maple Ridge, BC, V2X 8G1 1.800.490.1738 |
|
| General Inquiries - info@vitaaid.com Sponsor Inquiries - tomah@vitaaid.com |
|
|
|
|